0001264124-12-000037.txt : 20120210
0001264124-12-000037.hdr.sgml : 20120210
20120210205509
ACCESSION NUMBER: 0001264124-12-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120208
FILED AS OF DATE: 20120210
DATE AS OF CHANGE: 20120210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOLTERMAN ORVILLE G
CENTRAL INDEX KEY: 0001236394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19700
FILM NUMBER: 12594972
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000881464
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330266089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9360 TOWNE CENTRE DR
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 6195522200
MAIL ADDRESS:
STREET 1: 9360 TOWNE CENTRE DR
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2012-02-08
0
0000881464
AMYLIN PHARMACEUTICALS INC
AMLN
0001236394
KOLTERMAN ORVILLE G
9360 TOWNE CENTRE DR
SAN DIEGO
CA
92121
0
1
0
0
SVP, Chief Medical Officer
Common Stock
2012-02-08
4
A
0
15000
0
A
171456.9
D
Common Stock
2012-02-08
4
S
0
5637
16.6154
D
165819.9
D
Common Stock
12767.3
I
Indirect-401k
Common Stock
6445.1
I
by ESOP
Represents shares acquired upon vesting of performance-based restricted stock units.
Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units.
These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
By: /s/ James R. Oehler, Attorney-in-Fact For: Orville G. Kolterman
2012-02-10